Article
Lidocaine-induced Brugada syndrome phenotype linked to a novel double mutation in the cardiac sodium channel.
Circulation research - 15 Aug 2008
Barajas-Martínez Hector M, Hu Dan, Cordeiro Jonathan M, Wu Yuesheng, Kovacs Richard J, Meltser Henry, Kui Hong, Elena Burashnikov, Brugada Ramon, Antzelevitch Charles, Dumaine Robert
Abstract excerpt
Brugada syndrome has been linked to mutations in SCN5A. Agents that dissociate slowly from the sodium channel such as flecainide and ajmaline unmask the Brugada syndrome electrocardiogram and precipitate ventricular tachycardia/fibrillation. Lidocaine, an agent with rapid dissociation kinetics, has previously been shown to exert no effect in patients with Brugada syndrome. We characterized a novel double mutation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
